Since iron overload is correlated with AD pathogenesis [135], the suppression of ferroptosis by Nrf2-dependent induction of antioxidant enzymes (e.g., GPx4, SOD2, and HO-1) may provide a basis to explore their therapeutic potential in AD. This evidence concerns the gene HMOX1 and Alzheimer disease.